Where d we stand tday? Nte by the United Natins Secretary-General transmitting the reprt f the Directr-General f WHO n the preventin and cntrl f NCDs (10 December 2013) Paragraph 43. Remarkable prgress has been made since September 2011. Many cuntries, including sme f the prest, have aligned their plicies and resurces with the nine glbal targets and the WHO Glbal Actin Plan fr the Preventin and Cntrl f NCDs 2013-2020 t make unparalleled gains. Sizeable gains have ccurred in even the prest cuntries. Paragraph 44. Hwever, prgress has been insufficient and highly uneven. Blder measures are urgent t accelerate effrts t address NCDs and mitigate their impacts. The plitical declaratin has catalysed actin and retains great pwer in engendering cllective actin fr faster results.
Tipping pint
Rad map f cmmitments included in the 2011 UN Plitical Declaratin n NCDs 2011 Plitical Declaratin First High-level Meeting n NCDs (Wrld Leaders) Third High-level Meeting n NCDs 2018 2014 Outcme Dcument Secnd High-level Meeting n NCDs (Ministers)
Rad map f cmmitments included in the 2011 UN Plitical Declaratin n NCDs 2011 UN Plitical Declaratin n NCDs Radmap f cncrete natinal cmmitments, including ne timebund cmmitment: By 2013, cnsider develping natinal multisectral plicies and plans 2014 UN Outcme Dcument n NCDs Reiterated the same radmap f natinal cmmitments, including fur time-bund cmmitments: By 2015, cnsider setting natinal targets fr NCDs By 2015, cnsider develping natinal multisectral plicies and plans By 2016, implement best buys t reduce risk factrs fr NCDs By 2016, implement best buys t enable health systems t respnd
Which NCD plicies and prgrammes best drive prgress? Best buys Tbacc Reduce affrdability f tbacc prducts by increasing tbacc excise taxes Create by law cmpletely smke-free envirnments in all indr wrkplaces, public places and public transprt Warn peple f the dangers f tbacc and tbacc smke thrugh effective health warnings and mass media campaigns Ban all frms f tbacc advertising, prmtin and spnsrship Harmful use f alchl Regulate cmmercial and public availability f alchl Restrict r ban alchl advertising and prmtins Use pricing plicies such as excise tax increases n alchlic beverages
Which NCD plicies and prgrammes best drive prgress? Best buys Diet and physical activity Reduce salt intake Replace trans fats with unsaturated fats Implement public awareness prgrammes n diet and physical activity Prmte and prtect breastfeeding
Which NCD plicies and prgrammes best drive prgress? Best buys Cardivascular diseases and diabetes Drug therapy (including glycaemic cntrl fr diabetes mellitus and cntrl f hypertensin using a ttal risk apprach) and cunselling t individuals wh have had a heart attack r strke and t persns with high risk ( 30%) f a fatal and nnfatal cardivascular event in the next 10 years Acetylsalicylic acid (aspirin) fr acute mycardial infarctin Cancer Preventin f liver cancer thrugh hepatitis B immunizatin Preventin f cervical cancer thrugh screening (visual inspectin with acetic acid (VIA) linked with timely treatment f pre-cancerus lesins
Where t fcus: 9 glbal NCD targets t be attained by 2025 (against a 2010 baseline) A 25% relative reductin in risk f premature mrtality frm cardivascular disease, cancer, diabetes r chrnic respiratry diseases At least a 10% relative reductin in the harmful use f alchl A 10% relative reductin in prevalence f insufficient physical activity A 25% relative reductin in prevalence f raised bld pressure r cntain the prevalence f raised bld pressure A 30% relative reductin in prevalence f current tbacc use Halt the rise in diabetes and besity A 30% relative reductin in mean ppulatin intake f salt/sdium An 80% availability f the affrdable basic technlgies and essential medicines, incl. generics, required t treat NCDs At least 50% f eligible peple receive drug therapy and cunselling t prevent heart attacks and strkes
Guidance prvided thrugh WHO tls Available at www.wh.int/ncd Updated every three mnths
What gets measured gets dne 25 utcme indicatrs 2015 WHA68 (2016) 2020 WHA73 (2021) 2025 WHA78 (2026) 9 prcess indicatrs 2015 WHA68 (2016) 2017 WHA69 (2018) 2020 WHA73 (2021) 10 prgress indicatrs 2015 Prgress mnitr 2016 Prgress mnitr 2017 UNGA (2017)
Glbal baseline (2010) against which prgress will be measured Cuntry estimates f NCD mrtality and selected risk factrs (2010 baseline and latest available data) Premature mrtality NCD mrtality Alchl Insufficient physical activity Tbacc Bdy mass index Overweight and besity Raised bld glucse Raised bld pressure
Hw WHO is supprting dmestic actin n NCDs UN Task Frce n NCDs WHO Glbal NCD Actin Plan 2013-2020 WHO Reginal NCD Actin Plans WHO Prgramme Budget 2014-2015 (prpsed PB 2016-2017) WHO Glbal Crdinatin Mechanism n NCDs Outcme 2.1: Increased access t interventins t prevent and manage NCDs and their risk factrs Number f cuntries that have established natinal multisectral actin plans fr the preventin and cntrl f NCDs Number f cuntries that have integrated wrk n NCDs int their UNDAFs Number f cuntries reprting n the 9 vluntary targets
Time t scale up actin The 3rd UN High-level Meeting n NCDs is nly three years away
2015 2016 2017 2018 Getting t 2018 Jan 2015: WHO published glbal baseline May 2015: WHO published a technical nte n hw WHO will reprt t the UN General Assembly in 2017 taking int accunt 10 prgress mnitr indicatrs May 2015: WHO will cnduct the fifth (2015) glbal survey n assessing natinal capacity fr the preventin and cntrl f NCDs Sept 2015: WHO will publish an intermediate prgress reprt taking int accunt 10 prgress indicatrs and data cllected in 2015 May 2016: WHO will submit prgress reprt t Wrld Health Assembly n 25 utcme indicatrs and 9 prcess indicatrs April 2017: WHO will cnduct the sixth (2017) glbal survey n assessing natinal capacity n NCDs Sept 2017: WHO will submit a prgress reprt t the UN General Assembly, including a statistical annex with cuntry data n the 10 prgress indicatrs 2018: Third High-level Meeting f the United Natins General Assembly n NCDs